Explore Business Standard
Highdell Investment, which is owned by private equity major Warburg Pincus, on Tuesday divested 2.26 per cent stake in Kalyan Jewellers India Ltd for little over Rs 256 crore through an open market transaction. Following the deal, shares of Kalyan Jewellers plunged 9.06 per cent to settle at Rs 107.9 on the National Stock Exchange (NSE). According to bulk deal data available with the NSE, Highdell Investment sold a total of 2,33,25,686 shares of the jewellery chain company, amounting to 2.26 per cent stake in the company. The shares were offloaded at a price of Rs 110.04 apiece, taking the transaction size to Rs 256.67 crore, as per the data. However, the buyer of the shares could not be ascertained immediately. Highdell Investment owned 26.36 per cent stake in the company as of December quarter, latest shareholding data with the BSE showed. Kalyan Jewellers India Pvt Ltd is into manufacturing and sale of gems and jewellery. In December 2022, Kalyan Jewellers announced plans to
Vedanta Ltd on Thursday termed any talks of sale in oil-to-metals conglomerate as "untrue and baseless." This comes in the wake of news report which said that mining mogul Anil Agarwal is contemplating a stake sale in Vedanta as a last-resort option and is examining the possibility of selling less than 5 per cent of the company. According to company's spokesperson, "Any talk of stake sale in Vedanta Ltd is untrue and baseless." The media report said that stake sale in Vedanta is a last resort for Agarwal and will only be considered if other fundraising options fail. Vedanta Resources which is a majority shareholder of Vedanta Ltd has been looking to reduce its debt through the sale of its zinc assets for a cash consideration of USD 2,981 million to Hindustan Zinc Ltd (HZL). However, the government which holds 29.54 per cent stake in Hindustan Zinc has sternly opposed this move. Vedanta holds 64.92 per cent of the equity share capital of HZL. Vedanta Resources had earlier said t
Oliva Skin & Hair Clinic, which is a medico-aesthetic dermatology services player, has said it has sold majority stake to Kedaara Capital for a consideration of USD 65 million (around Rs 530 crore). With its third investment in the single speciality healthcare segment, Kedaara aims to fuel Oliva's growth towards becoming a leading medico-aesthetic dermatology chain, a statement said. The transaction also provides an exit to InvAscent, which invested in the company in 2014, it said, without disclosing the details such how much was invested and for what stake. Nor the company disclosed what is the stake that Kedaara has picked up. Founded by Prashant Soma in 2009, Oliva has been supported by multiple rounds of funding from InvAscent-advised India Life Sciences Fund II. Oliva grew from a four-centre Hyderabad-based operation to a network of 23 centres across Bengaluru, Chennai, Pune, Kolkata, Kochi and Vizag now and offers a range of skin and hair treatments and products. Kedaara is